SEARCH

SEARCH BY CITATION

References

  • Algaidi S. A., Christie L. A., Jenkinson A. M., Whalley L., Riedel G. and Platt B. (2006) Long-term homocysteine exposure induces alterations in spatial learning, hippocampal signalling and synaptic plasticity. Exp. Neurol. 197, 821.
  • Alonso A. C., Zaidi T., Grundke-Iqbal I. and Iqbal K. (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc. Natl Acad. Sci. USA 91, 55625566.
  • Arendt T., Holzer M., Fruth R., Bruckner M. K. and Gartner U. (1995) Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neuroscience 69, 691698.
  • Arendt T., Holzer M., Fruth R., Bruckner M. K. and Gartner U. (1998) Phosphorylation of tau, abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol. Aging 19, 313.
  • Bartschat D. K. and Rhodes T. E. (1995) Protein kinase C modulates calcium channels in isolated presynaptic nerve terminals of rat hippocampus. J. Neurochem. 64, 20642072.
  • Ben-Ari Y., Aniksztejn L. and Bregestovski P. (1992) Protein kinase C modulation of NMDA currents: an important link for LTP induction. Trends Neurosci. 15, 333339.
  • Bialojan C. and Takai A. (1988) Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem. J. 256, 283290.
  • Blackstone C., Murphy T. H., Moss S. J., Baraban J. M. and Huganir R. L. (1994) Cyclic AMP and synaptic activity-dependent phosphorylation of AMPA-preferring glutamate receptors. J. Neurosci. 14, 75857593.
  • Blank T., Nijholt I., Teichert U., Kugler H., Behrsing H., Fienberg A., Greengard P. and Spiess J. (1997) The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-d-aspartate responses. Proc. Natl Acad. Sci. USA 94, 1485914864.
  • Borthwick E. B., Zeke T., Prescott A. R. and Cohen P. T. (2001) Nuclear localization of protein phosphatase 5 is dependent on the carboxy-terminal region. FEBS Lett. 491, 279284.
  • Braak H. and Braak E. (1995) Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16, 271278; Discussion 278–84.
  • Brown G. P., Blitzer R. D., Connor J. H., Wong T., Shenolikar S., Iyengar R. and Landau E. M. (2000) Long-term potentiation induced by theta frequency stimulation is regulated by a protein phosphatase-1-operated gate. J. Neurosci. 20, 78807887.
  • Carrel J. E. and Eisner T. (1974) Cantharidin: potent feeding deterrent to insects. Science 183, 755757.
  • Choe E. S., Shin E. H. and Wang J. Q. (2005) Inhibition of protein phosphatase 2B upregulates serine phosphorylation of N-methyl-d-aspartate receptor NR1 subunits in striatal neurons in vivo. Neurosci. Lett. 384, 3843.
  • Cohen P. T. (1997) Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem. Sci. 22, 245251.
  • Colwell C. S. and Levine M. S. (1995) Excitatory synaptic transmission in neostriatal neurons: regulation by cyclic AMP-dependent mechanisms. J. Neurosci. 15, 17041713.
  • Deshpande A., Mina E., Glabe C. and Busciglio J. (2006) Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J. Neurosci. 26, 60116018.
  • Doerner D. and Alger B. E. (1992) Evidence for hippocampal calcium channel regulation by PKC based on comparison of diacylglycerols and phorbol esters. Brain Res. 597, 3040.
  • Drysdale A. J., Ryan D., Pertwee R. G. and Platt B. (2006) Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells. Neuropharmacology 50, 621631.
  • Ekinci F. J., Ortiz D. and Shea T. B. (2003) Okadaic acid mediates tau phosphorylation via sustained activation of the L-voltage-sensitive calcium channel. Brain Res. Mol. Brain Res. 117, 145151.
  • Fath T., Eidenmuller J. and Brandt R. (2002) Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer’s disease. J. Neurosci. 22, 97339741.
  • Gong C. X., Grundke-Iqbal I. and Iqbal K. (1994a) Dephosphorylation of Alzheimer’s disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience 61, 765772.
  • Gong C. X., Grundke-Iqbal I., Damuni Z. and Iqbal K. (1994b) Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease. FEBS Lett. 341, 9498.
  • Grueter C. E., Abiria S. A., Dzhura I., Wu Y., Ham A. J., Mohler P. J., Anderson M. E. and Colbran R. J. (2006) L-type Ca2+ channel facilitation mediated by phosphorylation of the beta subunit by CaMKII. Mol. Cell 23, 641650.
  • Hartman R. E., Izumi Y., Bales K. R., Paul S. M., Wozniak D. F. and Holtzman D. M. (2005) Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer’s disease. J. Neurosci. 25, 62136220.
  • Hastie C. J. and Cohen P. T. (1998) Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters. FEBS Lett. 431, 357361.
  • Hell J. W., Yokoyama C. T., Breeze L. J., Chavkin C. and Catterall W. A. (1995) Phosphorylation of presynaptic and postsynaptic calcium channels by cAMP-dependent protein kinase in hippocampal neurons. EMBO J. 14, 30363044.
  • Herzig S. and Neumann J. (2000) Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol. Rev. 80, 173210.
  • Hill J. J., Callaghan D. A., Ding W., Kelly J. F. and Chakravarthy B. R. (2006) Identification of okadaic acid-induced phosphorylation events by a mass spectrometry approach. Biochem. Biophys. Res. Commun. 342, 791799.
  • Hong S. J. (2000) Inhibition of mouse neuromuscular transmission and contractile function by okadaic acid and cantharidin. Br. J. Pharmacol. 130, 12111218.
  • Honkanen R. E. (1993) Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A. FEBS Lett. 330, 283286.
  • Hsu K. S., Huang C. C., Liang Y. C., Wu H. M., Chen Y. L., Lo S. W. and Ho W. C. (2002) Alterations in the balance of protein kinase and phosphatase activities and age-related impairments of synaptic transmission and long-term potentiation. Hippocampus 12, 787802.
  • Huang X. and Honkanen R. E. (1998) Molecular cloning, expression, and characterization of a novel human serine/threonine protein phosphatase, PP7, that is homologous to drosophila retinal degeneration C gene product (rdgC). J. Biol. Chem. 273, 14621468.
  • Hussain R. J. and Carpenter D. O. (2005) A comparison of the roles of protein kinase C in long-term potentiation in rat hippocampal areas CA1 and CA3. Cell Mol. Neurobiol. 25, 649661.
  • Iqbal K., Alonso Adel C., Chen S. et al. (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta 1739, 198210.
  • Jackson M. F., Konarski J. Z., Weerapura M., Czerwinski W. and MacDonald J. F. (2006) Protein kinase C enhances glycine-insensitive desensitization of NMDA receptors independently of previously identified protein kinase C sites. J. Neurochem. 96, 15091518.
  • Jacobsen J. S., Wu C. C., Redwine J. M. et al. (2006) Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer’s disease. Proc. Natl Acad. Sci. USA 103, 51615166.
  • Jouvenceau A., Billard J. M., Haditsch U., Mansuy I. M. and Dutar P. (2003) Different phosphatase-dependent mechanisms mediate long-term depression and depotentiation of long-term potentiation in mouse hippocampal CA1 area. Eur. J. Neurosci. 18, 12791285.
  • Kapur J. and Macdonald R. L. (1996) Cyclic AMP-dependent protein kinase enhances hippocampal dentate granule cell GABAA receptor currents. J. Neurophysiol. 76, 26262634.
  • Kim D., Su J. and Cotman C. W. (1999) Sequence of neurodegeneration and accumulation of phosphorylated tau in cultured neurons after okadaic acid treatment. Brain Res. 839, 253262.
  • Ko H. W., Han K. S., Kim E. Y., Ryu B. R., Yoon W. J., Jung Y. K., Kim S. U. and Gwag B. J. (2000) Synergetic activation of p38 mitogen-activated protein kinase and caspase-3-like proteases for execution of calyculin A-induced apoptosis but not N-methyl-d-aspartate-induced necrosis in mouse cortical neurons. J. Neurochem. 74, 24552461.
  • Leonard A. S. and Hell J. W. (1997) Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-d-aspartate receptors at different sites. J. Biol. Chem. 272, 1210712115.
  • Li Y. M. and Casida J. E. (1992) Cantharidin-binding protein: identification as protein phosphatase 2A. Proc. Natl Acad. Sci. USA 89, 1186711870.
  • Li L., Sengupta A., Haque N., Grundke-Iqbal I. and Iqbal K. (2004) Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration. FEBS Lett. 566, 261269.
  • Lisman J. (1989) A mechanism for the hebb and the anti-hebb processes underlying learning and memory. Proc. Natl Acad. Sci. USA 86, 95749578.
  • Liu F., Grundke-Iqbal I., Iqbal K. and Gong C. X. (2005a) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22, 19421950.
  • Liu F., Iqbal K., Grundke-Iqbal I., Rossie S. and Gong C. X. (2005b) Dephosphorylation of tau by protein phosphatase 5: impairment in Alzheimer’s disease. J. Biol. Chem. 280, 17901796.
  • Lu Y. F., Hayashi Y., Moriwaki A., Tomizawa K. and Matsui H. (1996a) FK506, a Ca2+/calmodulin-dependent phosphatase inhibitor, inhibits the induction of long-term potentiation in the rat hippocampus. Neurosci. Lett. 205, 103106.
  • Lu Y. F., Tomizawa K., Moriwaki A., Hayashi Y., Tokuda M., Itano T., Hatase O. and Matsui H. (1996b) Calcineurin inhibitors, FK506 and cyclosporin A, suppress the NMDA receptor-mediated potentials and LTP, but not depotentiation in the rat hippocampus. Brain Res. 729, 142146.
  • MacDonald J. F., Kotecha S. A., Lu W. Y. and Jackson M. F. (2001) Convergence of PKC-dependent kinase signal cascades on NMDA receptors. Curr. Drug Targets 2, 299312.
  • Malleret G., Haditsch U., Genoux D., Jones M. W., Bliss T. V., Vanhoose A. M., Weitlauf C., Kandel E. R., Winder D. G. and Mansuy I. M. (2001) Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell 104, 675686.
  • Manusy I. M. and Shenolikar S. (2006) Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory. TINS 29, 679686.
  • Markram H. and Segal M. (1992) Activation of protein kinase C suppresses responses to NMDA in rat CA1 hippocampal neurones. J. Physiol. 457, 491501.
  • Merrick S. E., Trojanowski J. Q. and Lee V. M. (1997) Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J. Neurosci. 17, 57265737.
  • Mishizen-Eberz A. J., Rissman R. A., Carter T. L., Ikonomovic M. D., Wolfe B. B. and Armstrong D. M. (2004) Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer’s disease pathology. Neurobiol. Dis. 15, 8092.
  • Munoz T. E., Giberson R. T., Demaree R. and Day J. R. (2004) Microwave-assisted immunostaining: a new approach yields fast and consistent results. J. Neurosci. Methods 137, 133139.
  • Niewiadomska G., Baksalerska-Pazera M., Lenarcik I. and Riedel G. (2006) Compartmental protein expression of tau, GSK-3beta and TrkA in cholinergic neurons of aged rats. J. Neural Transm. 113, 17331746.
  • Nijholt I., Blank T., Liu A., Kugler H. and Spiess J. (2000) Modulation of hypothalamic NMDA receptor function by cyclic AMP-dependent protein kinase and phosphatases. J. Neurochem. 75, 749754.
  • Ninan I. and Arancio O. (2004) Presynaptic CaMKII is necessary for synaptic plasticity in cultured hippocampal neurons. Neuron 42, 129141.
  • Oddo S., Caccamo A., Shepherd J. D., Murphy M. P., Golde T. E., Kayed R., Metherate R., Mattson M. P., Akbari Y. and LaFerla F. M. (2003) Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular abeta and synaptic dysfunction. Neuron 39, 409421.
  • Platt B., Drysdale A. J., Nday C., Roloff E. v. L., Drever B. and Salifoglou T. (2007) Differential toxicity of novel aluminium compounds in hippocampal culture. Neurotoxicology. doi:10.1016/j.neuro.2006.12.008.
  • Potier B., Poindessous-Jazat F., Dutar P. and Billard J. M. (2000) NMDA receptor activation in the aged rat hippocampus. Exp. Gerontol. 35, 11851199.
  • Raman I. M., Tong G. and Jahr C. E. (1996) Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron 16, 415421.
  • Riedel G. (1999) If phosphatases go up, memory goes down. Cell Mol. Life Sci. 55, 549553.
  • Sánchez-Pérez A. M. and Felipo V. (2005) Serines 890 and 896 of the NMDA receptor subunit NR1 are differentially phosphorylated by protein kinase C isoforms. Neurochem. Int. 47, 8491.
  • Sim A. T., Lloyd H. G., Jarvie P. E., Morrison M., Rostas J. A. and Dunkley P. R. (1993) Synaptosomal amino acid release: effect of inhibiting protein phosphatases with okadaic acid. Neurosci. Lett. 160, 181184.
  • Smart T. G. (1997) Regulation of excitatory and inhibitory neurotransmitter-gated ion channels by protein phosphorylation. Curr. Opin. Neurobiol. 7, 358367.
  • Sontag E., Luangpirom A., Hladik C., Mudrak I., Ogris E., Speciale S. and White III C. L. (2004) Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J. Neuropathol. Exp. Neurol. 63, 287301.
  • Sun L., Liu S. Y., Zhou X. W., Wang X. C., Liu R., Wang Q. and Wang J. Z. (2003) Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 118, 11751182.
  • Sze C., Bi H., Kleinschmidt-DeMasters B. K., Filley C. M. and Martin L. J. (2001) N-methyl-d-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer’s disease. J. Neurol. Sci. 182, 151159.
  • Tanimukai H., Grundke-Iqbal I. and Iqbal K. (2005) Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer’s disease. Am. J. Pathol. 166, 17611771.
  • Vogelsberg-Ragaglia V., Schuck T., Trojanowski J. Q. and Lee V. M. (2001) PP2A mRNA expression is quantitatively decreased in Alzheimer’s disease hippocampus. Exp. Neurol. 168, 402412.
  • Wang J. H. and Kelly P. T. (1995) Postsynaptic injection of Ca2+/CaM induces synaptic potentiation requiring CaMKII and PKC activity. Neuron 15, 443452.
  • Wang J. H. and Stelzer A. (1994) Inhibition of phosphatase 2B prevents expression of hippocampal long-term potentiation. Neuroreport 5, 23772380.
  • Wang L. Y., Orser B. A., Brautigan D. L. and MacDonald J. F. (1994) Regulation of NMDA receptors in cultured hippocampal neurons by protein phosphatases 1 and 2A. Nature 369, 230232.
  • Wang J. Z., Gong C. X., Zaidi T., Grundke-Iqbal I. and Iqbal K. (1995) Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J. Biol. Chem. 270, 48544860.
  • Yan Y., Shay J. W., Wright W. E. and Mumby M. C. (1997) Inhibition of protein phosphatase activity induces p53-dependent apoptosis in the absence of p53 transactivation. J. Biol. Chem. 272, 1522015226.
  • Zeng H., Chattarji S., Barbarosie M., Rondi-Reig L., Philpot B. D., Miyakawa T., Bear M. F. and Tonegawa S. (2001) Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 107, 617629.